# 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

> **NCT07508852** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 30 (estimated)

## Conditions studied

- SCLC
- SCLC, Extensive Stage
- SCLC, Limited Stage
- Small Cell Lung Cancer
- Small Cell Lung Cancer ( SCLC )

## Interventions

- **DIAGNOSTIC_TEST:** Sequential [18F]-FDG PET/CT
- **DIAGNOSTIC_TEST:** [68Ga]Ga-PFD3 PET/CT scan

## Key facts

- **NCT ID:** NCT07508852
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07508852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07508852, "68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07508852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*